NO166836C - Fremgangsmaate for behandling av et organtransplantat. - Google Patents

Fremgangsmaate for behandling av et organtransplantat.

Info

Publication number
NO166836C
NO166836C NO860858A NO860858A NO166836C NO 166836 C NO166836 C NO 166836C NO 860858 A NO860858 A NO 860858A NO 860858 A NO860858 A NO 860858A NO 166836 C NO166836 C NO 166836C
Authority
NO
Norway
Prior art keywords
procedure
treatment
organ transplant
transplant
layer
Prior art date
Application number
NO860858A
Other languages
English (en)
Norwegian (no)
Other versions
NO860858L (no
NO166836B (no
Inventor
Kent C Cochrum
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO860858L publication Critical patent/NO860858L/no
Publication of NO166836B publication Critical patent/NO166836B/no
Publication of NO166836C publication Critical patent/NO166836C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Chemically Coating (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Fertilizers (AREA)
  • Electroplating Methods And Accessories (AREA)
  • Catalysts (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
NO860858A 1985-03-14 1986-03-07 Fremgangsmaate for behandling av et organtransplantat. NO166836C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71166485A 1985-03-14 1985-03-14

Publications (3)

Publication Number Publication Date
NO860858L NO860858L (no) 1986-09-15
NO166836B NO166836B (no) 1991-06-03
NO166836C true NO166836C (no) 1991-09-11

Family

ID=24859010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860858A NO166836C (no) 1985-03-14 1986-03-07 Fremgangsmaate for behandling av et organtransplantat.

Country Status (10)

Country Link
US (1) US4696286A (de)
EP (1) EP0195577B1 (de)
JP (1) JPH07100661B2 (de)
AT (1) ATE75409T1 (de)
CA (1) CA1267851A (de)
DE (1) DE3685046D1 (de)
DK (1) DK165221C (de)
FI (1) FI90628C (de)
IL (1) IL78110A (de)
NO (1) NO166836C (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935000A (en) * 1986-04-03 1990-06-19 East Carolina University Extracellular matrix induction method to produce pancreatic islet tissue
DE69018691T2 (de) * 1989-05-11 1995-08-17 Kanegafuchi Chemical Ind Medizinische Anordnung mit hochbiokompatibler Oberfläche und Verfahren zu deren Herstellung.
ATE147613T1 (de) * 1989-09-15 1997-02-15 Chiron Vision Corp Synthetisches material, das die anlagerung, das wachstum und die befestigung von epithelzellen fördert, prosthetische vorrichtung zur subepithelialen implantation sowie behandelte linse
IL103284A0 (en) * 1991-10-31 1993-02-21 Transtech Medical Inc Transplant protective coating
US6231881B1 (en) * 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US5834005A (en) * 1992-02-24 1998-11-10 Encelle, Inc. Bioartificial devices and cellular matrices therefor
DE69327281T2 (de) * 1992-02-24 2000-08-10 Encelle, Inc. Künstliche endokrine vorrichtung
US5824331A (en) * 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5429821A (en) * 1992-05-29 1995-07-04 The Regents Of The University Of California Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
US5578314A (en) * 1992-05-29 1996-11-26 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
AU4402793A (en) * 1992-05-29 1993-12-30 Regents Of The University Of California, The Coated transplant and method for making same
US5399665A (en) * 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
AU6243294A (en) * 1993-02-18 1994-09-14 New England Deaconess Hospital Corporation Implantable artificial organ
WO1994028897A2 (en) * 1993-06-07 1994-12-22 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
US5876742A (en) * 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
WO1995031944A1 (en) * 1994-05-20 1995-11-30 Vec Tec, Inc. Methods rendering grafts nonthrombogenic and substantially nonimmunogenic
DE69535920D1 (de) * 1994-05-20 2009-04-09 Breonics Inc Verfahren zur überwachung der lebensfähigkeit transplantabler organe
US5882328A (en) * 1995-01-13 1999-03-16 Qlt Phototherapeutics, Inc. Method to prevent transplant rejection
CA2214088A1 (en) * 1995-03-03 1996-09-12 Metabolex Inc. Novel encapsulation process by a gelling polymer
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods
US6060640A (en) * 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
EP0747046A3 (de) * 1995-05-19 1997-12-03 Baxter International Inc. Durchlässige Immunoisolationsmembranstrukturen für Zellimplantation in einem Wirtsgewebe
EP0877555B1 (de) * 1995-09-27 2007-08-22 Emory University Verwendung eines inhibitors eines kostimulatorischen vorgangs des immunsystems zur herstellung eines medikaments zum schutz transplantierter, nichtembryonaler lebender zellen vor zerstörung durch das immunsystem
US7041634B2 (en) 1995-09-27 2006-05-09 Emory University Method of inhibiting immune system destruction of transplanted viable cells
US5855613A (en) * 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
DE69634859D1 (de) * 1995-10-26 2005-07-21 Paul P Latta Induktion von immunologischer toleranz
JPH11508477A (ja) * 1996-02-23 1999-07-27 サーシ・バイオメディカル・インコーポレーテッド 新規の人工膵臓
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
EP1731175B1 (de) * 1998-11-12 2009-09-30 International Manufacturing Group, Inc. Hämostatische vernetzte Dextranperlen verwendbar zur schnellen Blutgerinnung und Hämostase
US6605115B1 (en) * 1999-06-05 2003-08-12 Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
EP1224259A4 (de) * 1999-09-27 2005-04-27 Univ Florida Rückbildung von insulinabhängigem diabetes durch inselbildende stammzellen, inselvorläuferzellen und inselähnliche strukturen
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
WO2001070022A1 (fr) * 2000-03-21 2001-09-27 Yuichi Mori Materiaux de revetement pour tissus biologiques, tissus biologiques revetus et procede d'enduction de tissus biologiques
WO2001091773A2 (en) 2000-05-31 2001-12-06 Encelle, Inc. Method of stimulating hair growth
WO2002002745A2 (en) * 2000-07-05 2002-01-10 Islet Technology, Inc. Method and system for consistent and effective encapsulation of biological material
KR100380569B1 (ko) * 2000-10-24 2003-04-26 주식회사 메디프렉스 고분자 결합을 이용한 췌장소도 막의 표면개질 방법
AU2002214443B2 (en) 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
AU2002361902A1 (en) * 2001-12-31 2003-07-24 Ares Medical, Inc. Hemostatic compositions and methods for controlling bleeding
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
NZ579362A (en) * 2007-02-02 2012-03-30 Univ Miami Therapeutic hybrid implantable devices
US20100021538A1 (en) * 2008-02-29 2010-01-28 Youngro Byun Pharmaceutical compositions containing heparin derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6915369D0 (pt) * 1969-02-27 1973-03-13 Bayer Ag Emprego de inibidores biologicos de proteases para conservacao de orgaos tecidos e alimentos
US3629390A (en) * 1969-12-18 1971-12-21 Us Interior Avian specific bio-affecting preparation and treatment method
IL47062A (en) * 1975-04-10 1979-07-25 Yeda Res & Dev Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
US4251387A (en) * 1979-04-17 1981-02-17 Damon Corporation Process for preparing semipermeable microcapsules
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
JPS6059010B2 (ja) * 1979-10-02 1985-12-23 工業技術院長 マイクロカプセル
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4407957A (en) * 1981-03-13 1983-10-04 Damon Corporation Reversible microencapsulation of a core material
US4495288A (en) * 1981-03-13 1985-01-22 Damon Biotech, Inc. Method of culturing anchorage dependent cells
US4439521A (en) * 1981-10-21 1984-03-27 Ontario Cancer Institute Method for producing self-reproducing mammalian pancreatic islet-like structures
JPS6018179A (ja) * 1983-07-12 1985-01-30 三浦　喜温 人工肝臓用材料
IL72787A (en) * 1983-09-01 1987-12-31 Damon Biotech Inc Polyionic microencapsulation of viable cells
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
GB8500121D0 (en) * 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells

Also Published As

Publication number Publication date
FI861083A0 (fi) 1986-03-14
NO860858L (no) 1986-09-15
JPH07100661B2 (ja) 1995-11-01
ATE75409T1 (de) 1992-05-15
DK165221C (da) 1993-03-22
JPS61222443A (ja) 1986-10-02
EP0195577B1 (de) 1992-04-29
EP0195577A2 (de) 1986-09-24
IL78110A (en) 1991-04-15
FI90628C (fi) 1994-03-10
US4696286A (en) 1987-09-29
DK165221B (da) 1992-10-26
CA1267851A (en) 1990-04-17
EP0195577A3 (en) 1988-08-03
NO166836B (no) 1991-06-03
DK119286D0 (da) 1986-03-14
IL78110A0 (en) 1986-07-31
FI90628B (fi) 1993-11-30
DK119286A (da) 1986-09-15
DE3685046D1 (de) 1992-06-04
FI861083L (fi) 1986-09-15

Similar Documents

Publication Publication Date Title
NO860858L (no) Belagte transplantater og fremgangsmaate for fremstilling derav.
DK239388A (da) Fremgangsmaade til behandling af ikke-specifik inflammation
DK442783D0 (da) Fremgangsmade til fremstilling af et immobiliseret enzympraeparat
IT1150682B (it) Procedimento per la produzione di sostanze prodotte da cellule,particolarmente di anticorpi e simili
IT1126600B (it) Procedimento per la produzione di singole pietre ornamentali rivestite con adesivo termoattivato
AU5766290A (en) Soil-less culture element
DE59306762D1 (de) Aktivierte Trägermaterialien, ihre Herstellung und Verwendung
ATE84796T1 (de) Polypeptide mit einer laminin-wirksamkeit.
DK554486D0 (da) Substrat til kulturplante
DE3852939D1 (de) Verfahren zur Beschichtung künstlicher optischer Substrate.
DE3864512D1 (de) Verfahren zur herstellung von kandis mit gepressten gaszellen.
DK271588D0 (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
SE8604991D0 (sv) Snake venom growth arresting peptide
NO159607C (no) Fremgangsmaate for fremstilling av biokompatibelt materialved immobilisering av apyrase paa materialets overflate.
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.
DE69221826D1 (de) Aufgetragene Mikrokugeln
EP0336964A4 (de) Antithrombotische arzneimittel und deren herstellung.
DK160270C (da) Fremgangsmaade til fremstilling af 2,4- eller 2,4,5-substituerede 6-hydroxypyrimidiner
DE69302317D1 (de) Oligosaccharides
DK200387A (da) Fremgangsmaade til vedhaeftning af biologiske stoffer til faste substrater
DK183788A (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
DK241688D0 (da) Fremgangsmaade til fremstilling af fusionsproteiner
NO164356C (no) Fremgangsmaate for fremstilling av formskummede polyuretankomposittmaterialer.
DE3862218D1 (de) Verbundfolie zur herstellung von quaderfoermigen evakuierten packungen.
JPS53140973A (en) Forming method of semiconductor insulation film